Global Modafinil Market Growth 2025-2031

Publication ID:

LPI04255035

Publication Date:

April 23, 2025

Pages:

110

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Modafinil market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Modafinil, sold under the brand name听Provigil听among others, is a听central nervous system听(CNS)听stimulant听medication used to treat听sleepiness听due to听narcolepsy,听shift work sleep disorder, and听obstructive sleep apnea
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淢odafinil Industry Forecast鈥� looks at past sales and reviews total world Modafinil sales in 2024, providing a comprehensive analysis by region and market sector of projected Modafinil sales for 2025 through 2031. With Modafinil sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Modafinil industry.
This Insight Report provides a comprehensive analysis of the global Modafinil landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Modafinil portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Modafinil market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Modafinil and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Modafinil.
This report presents a comprehensive overview, market shares, and growth opportunities of Modafinil market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
100Mg
200Mg
Segmentation by Application:
Narcolepsy
Multiple Sclerosis (MS) Fatigue
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Welman Pharma
Orion
Acino
Teva
Alembic Pharma
Apotex
Appco Pharma
Arrow Pharma
Ascent Innovative Medicines
Auro Laboratories
Aurobindo Pharma
Cadila Pharma
Sun Pharma
Cephalon
Chanelle Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Modafinil market?
What factors are driving Modafinil market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Modafinil market opportunities vary by end market size?
How does Modafinil break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Modafinil Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Modafinil by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Modafinil by Country/Region, 2020, 2024 & 2031
2.2 Modafinil Segment by Type
2.2.1 100Mg
2.2.2 200Mg
2.3 Modafinil Sales by Type
2.3.1 Global Modafinil Sales Market Share by Type (2020-2025)
2.3.2 Global Modafinil Revenue and Market Share by Type (2020-2025)
2.3.3 Global Modafinil Sale Price by Type (2020-2025)
2.4 Modafinil Segment by Application
2.4.1 Narcolepsy
2.4.2 Multiple Sclerosis (MS) Fatigue
2.5 Modafinil Sales by Application
2.5.1 Global Modafinil Sale Market Share by Application (2020-2025)
2.5.2 Global Modafinil Revenue and Market Share by Application (2020-2025)
2.5.3 Global Modafinil Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Modafinil Breakdown Data by Company
3.1.1 Global Modafinil Annual Sales by Company (2020-2025)
3.1.2 Global Modafinil Sales Market Share by Company (2020-2025)
3.2 Global Modafinil Annual Revenue by Company (2020-2025)
3.2.1 Global Modafinil Revenue by Company (2020-2025)
3.2.2 Global Modafinil Revenue Market Share by Company (2020-2025)
3.3 Global Modafinil Sale Price by Company
3.4 Key Manufacturers Modafinil Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Modafinil Product Location Distribution
3.4.2 Players Modafinil Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Modafinil by Geographic Region
4.1 World Historic Modafinil Market Size by Geographic Region (2020-2025)
4.1.1 Global Modafinil Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Modafinil Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Modafinil Market Size by Country/Region (2020-2025)
4.2.1 Global Modafinil Annual Sales by Country/Region (2020-2025)
4.2.2 Global Modafinil Annual Revenue by Country/Region (2020-2025)
4.3 Americas Modafinil Sales Growth
4.4 APAC Modafinil Sales Growth
4.5 Europe Modafinil Sales Growth
4.6 Middle East & Africa Modafinil Sales Growth
5 Americas
5.1 Americas Modafinil Sales by Country
5.1.1 Americas Modafinil Sales by Country (2020-2025)
5.1.2 Americas Modafinil Revenue by Country (2020-2025)
5.2 Americas Modafinil Sales by Type (2020-2025)
5.3 Americas Modafinil Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Modafinil Sales by Region
6.1.1 APAC Modafinil Sales by Region (2020-2025)
6.1.2 APAC Modafinil Revenue by Region (2020-2025)
6.2 APAC Modafinil Sales by Type (2020-2025)
6.3 APAC Modafinil Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Modafinil by Country
7.1.1 Europe Modafinil Sales by Country (2020-2025)
7.1.2 Europe Modafinil Revenue by Country (2020-2025)
7.2 Europe Modafinil Sales by Type (2020-2025)
7.3 Europe Modafinil Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Modafinil by Country
8.1.1 Middle East & Africa Modafinil Sales by Country (2020-2025)
8.1.2 Middle East & Africa Modafinil Revenue by Country (2020-2025)
8.2 Middle East & Africa Modafinil Sales by Type (2020-2025)
8.3 Middle East & Africa Modafinil Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Modafinil
10.3 Manufacturing Process Analysis of Modafinil
10.4 Industry Chain Structure of Modafinil
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Modafinil Distributors
11.3 Modafinil Customer
12 World Forecast Review for Modafinil by Geographic Region
12.1 Global Modafinil Market Size Forecast by Region
12.1.1 Global Modafinil Forecast by Region (2026-2031)
12.1.2 Global Modafinil Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Modafinil Forecast by Type (2026-2031)
12.7 Global Modafinil Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Welman Pharma
13.1.1 Welman Pharma Company Information
13.1.2 Welman Pharma Modafinil Product Portfolios and Specifications
13.1.3 Welman Pharma Modafinil Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Welman Pharma Main Business Overview
13.1.5 Welman Pharma Latest Developments
13.2 Orion
13.2.1 Orion Company Information
13.2.2 Orion Modafinil Product Portfolios and Specifications
13.2.3 Orion Modafinil Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Orion Main Business Overview
13.2.5 Orion Latest Developments
13.3 Acino
13.3.1 Acino Company Information
13.3.2 Acino Modafinil Product Portfolios and Specifications
13.3.3 Acino Modafinil Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Acino Main Business Overview
13.3.5 Acino Latest Developments
13.4 Teva
13.4.1 Teva Company Information
13.4.2 Teva Modafinil Product Portfolios and Specifications
13.4.3 Teva Modafinil Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Teva Main Business Overview
13.4.5 Teva Latest Developments
13.5 Alembic Pharma
13.5.1 Alembic Pharma Company Information
13.5.2 Alembic Pharma Modafinil Product Portfolios and Specifications
13.5.3 Alembic Pharma Modafinil Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Alembic Pharma Main Business Overview
13.5.5 Alembic Pharma Latest Developments
13.6 Apotex
13.6.1 Apotex Company Information
13.6.2 Apotex Modafinil Product Portfolios and Specifications
13.6.3 Apotex Modafinil Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Apotex Main Business Overview
13.6.5 Apotex Latest Developments
13.7 Appco Pharma
13.7.1 Appco Pharma Company Information
13.7.2 Appco Pharma Modafinil Product Portfolios and Specifications
13.7.3 Appco Pharma Modafinil Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Appco Pharma Main Business Overview
13.7.5 Appco Pharma Latest Developments
13.8 Arrow Pharma
13.8.1 Arrow Pharma Company Information
13.8.2 Arrow Pharma Modafinil Product Portfolios and Specifications
13.8.3 Arrow Pharma Modafinil Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Arrow Pharma Main Business Overview
13.8.5 Arrow Pharma Latest Developments
13.9 Ascent Innovative Medicines
13.9.1 Ascent Innovative Medicines Company Information
13.9.2 Ascent Innovative Medicines Modafinil Product Portfolios and Specifications
13.9.3 Ascent Innovative Medicines Modafinil Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Ascent Innovative Medicines Main Business Overview
13.9.5 Ascent Innovative Medicines Latest Developments
13.10 Auro Laboratories
13.10.1 Auro Laboratories Company Information
13.10.2 Auro Laboratories Modafinil Product Portfolios and Specifications
13.10.3 Auro Laboratories Modafinil Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Auro Laboratories Main Business Overview
13.10.5 Auro Laboratories Latest Developments
13.11 Aurobindo Pharma
13.11.1 Aurobindo Pharma Company Information
13.11.2 Aurobindo Pharma Modafinil Product Portfolios and Specifications
13.11.3 Aurobindo Pharma Modafinil Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Aurobindo Pharma Main Business Overview
13.11.5 Aurobindo Pharma Latest Developments
13.12 Cadila Pharma
13.12.1 Cadila Pharma Company Information
13.12.2 Cadila Pharma Modafinil Product Portfolios and Specifications
13.12.3 Cadila Pharma Modafinil Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Cadila Pharma Main Business Overview
13.12.5 Cadila Pharma Latest Developments
13.13 Sun Pharma
13.13.1 Sun Pharma Company Information
13.13.2 Sun Pharma Modafinil Product Portfolios and Specifications
13.13.3 Sun Pharma Modafinil Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Sun Pharma Main Business Overview
13.13.5 Sun Pharma Latest Developments
13.14 Cephalon
13.14.1 Cephalon Company Information
13.14.2 Cephalon Modafinil Product Portfolios and Specifications
13.14.3 Cephalon Modafinil Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Cephalon Main Business Overview
13.14.5 Cephalon Latest Developments
13.15 Chanelle Medical
13.15.1 Chanelle Medical Company Information
13.15.2 Chanelle Medical Modafinil Product Portfolios and Specifications
13.15.3 Chanelle Medical Modafinil Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Chanelle Medical Main Business Overview
13.15.5 Chanelle Medical Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂